Form D · Biotechnology

OrPro Therapeutics, Inc.

San Diego, CA · CIK 0001594679

Offering snapshot reported Feb 17, 2016 · SEC filing

Reported sold
$2.34M
Indefinite offering
Investors reported
22
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 11, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.17M$2.34MDec 18, 2013: $1,327,498.00Dec 18, 2013Feb 17, 2016: $2,337,994.00Feb 17, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,327,498 → $2,337,994
  • Reported investors12 → 22

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 17, 2016Amendment$2,337,994$1,010,496vs Dec 18, 201322SEC filing
Dec 18, 2013Initial$1,327,498No comparison12SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-208254

Source: Form D, filed Feb 17, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Cam L. Garner Director, Executive
Peter B. Heifetz, Ph.D. Director, Executive
Mary Jacqueline Johnson Director
Jeffrey W. Raser Director
James Weil Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
C/O Latham & Watkins Llp 12636 High Bluff Dr., Suite 400
San Diego, CA, 92130